NCT06460896View on ClinicalTrials.gov

Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs

NANot yet recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Bypass Bariatric Surgery
Interventions
OTHER

pharmacokinetic study

Multicenter pharmacokinetic study of the bioavailability of four compounds in GBP patients: candesartan, amlodipine, metformin and rosuvastatin.

Trial Locations (1)

93000

Service de chirurgie digestive, bariatrique et endocrinienne, Bobigny

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06460896 - Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs | Biotech Hunter | Biotech Hunter